Overall Survival And Long-Term Safety Data From The Netter-1 Trial: 177-Lu-Dotatate Vs. High-Dose Octreotide In Patients With Progressive Midgut NetsJ. Strosberg,M. Caplin,P. Kunz,P. Ruszniewski,L. Bodei,A. Hendifar,E. Mittra,E. Wolin,J. Yao, M. Pavel,E. Grande Pulido,E. Van Cutsem,E. Seregni, H. Duarte, G. Gericke, A. Bartalotta, A. Demange, S. Mutevelic, E. KrenningANNALS OF ONCOLOGY（2021）引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
